SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+1.81%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$565M
AUM Growth
+$565M
(+7.2%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
7.88%
Top 10 Holdings %
Top 10 Hldgs %
54.35%
Holding
80
New
28
Increased
15
Reduced
12
Closed
13
Top Buys
| 1 |
Biogen
BIIB
|
$14.8M |
| 2 |
Sanofi
SNY
|
$14M |
| 3 |
Palo Alto Networks
PANW
|
$10.3M |
| 4 |
WIX.com
WIX
|
$10.1M |
| 5 |
Kornit Digital
KRNT
|
$8.59M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$32.5M |
| 2 |
FIVE9
FIVN
|
$12.8M |
| 3 |
Relmada Therapeutics
RLMD
|
$10.1M |
| 4 |
Altimmune
ALT
|
$10.1M |
| 5 |
Nice
NICE
|
$9.85M |
Sector Composition
| 1 | Healthcare | 84.24% |
| 2 | Technology | 9.15% |
| 3 | Industrials | 1.52% |
| 4 | Consumer Discretionary | 1.48% |
| 5 | Communication Services | 1.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ultragenyx Pharmaceutical
RARE
$2.89B
| $7.19M | 1% | +173,696 | New | +$7.19M |
|
27
SentinelOne
S
$6.29B
| $7.16M | 0.99% | +280,000 | New | +$7.16M |
|
|
28
Relmada Therapeutics
RLMD
$37.2M
| $7.15M | 0.99% | 193,230 -273,600 | -59% | -$10.1M |
|
|
ALBO
29
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $6.95M | 0.96% | +359,000 | New | +$6.95M |
|
30
SolarEdge
SEDG
$2.01B
| $6.81M | 0.95% | +29,426 | New | +$6.81M |
|
31
Gilead Sciences
GILD
$140B
| $6.48M | 0.9% | +105,090 | New | +$6.48M |
|
|
CNCE
32
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.38M | 0.89% | 952,783 +273,383 | +40% | +$1.83M |
|
33
Merus
MRUS
$4.98B
| $6.28M | 0.87% | 313,326 -95,835 | -23% | -$1.92M |
|
34
Arcellx
ACLX
$3.85B
| $6.27M | 0.87% | +334,080 | New | +$6.27M |
|
35
Teva Pharmaceuticals
TEVA
$21.1B
| $6.27M | 0.87% | 776,346 -371,532 | -32% | -$3M |
|
|
BLU
36
DELISTED
BELLUS Health Inc.
BLU
| $4.91M | 0.68% | +464,860 | New | +$4.91M |
|
37
NVIDIA
NVDA
$4.24T
| $4.86M | 0.67% | 40,000 +28,712 | +254% | +$3.49M |
|
|
CINC
38
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $3.9M | 0.54% | +118,950 | New | +$3.9M |
|
39
89bio
ETNB
$1.34B
| $3.81M | 0.53% | 658,784 +208,784 | +46% | +$1.21M |
|
40
Rezolute
RZLT
$619M
| $3.17M | 0.44% | 1,155,897 | – | – |
|
|
INZY
41
DELISTED
Inozyme Pharma
INZY
| $3.15M | 0.44% | 1,175,058 +9,458 | +0.8% | +$25.3K |
|
|
DICE
42
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.1M | 0.43% | +152,913 | New | +$3.1M |
|
43
Werewolf Therapeutics
HOWL
$59.9M
| $2.83M | 0.39% | 626,810 +29,807 | +5% | +$134K |
|
44
Rigel Pharmaceuticals
RIGL
$697M
| $2.55M | 0.35% | 2,162,586 -362,414 | -14% | -$428K |
|
45
PMV Pharmaceuticals
PMVP
$74.2M
| $2.24M | 0.31% | 187,800 | – | – |
|
46
Stoke Therapeutics
STOK
$1.08B
| $2.02M | 0.28% | +157,200 | New | +$2.02M |
|
47
Sunrun
RUN
$3.68B
| $1.79M | 0.25% | +65,000 | New | +$1.79M |
|
|
INFI
48
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.76M | 0.24% | +1,476,000 | New | +$1.76M |
|
|
ALPN
49
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.44M | 0.2% | +200,000 | New | +$1.44M |
|
|
MGIC
50
Magic Software Enterprises
MGIC
$997M
| $1.27M | 0.18% | 81,293 | – | – |
|